retatrutide gip glp-1 glucagon receptor agonist vs. Tirzepatide: The Next-Gen Showdown Retatrutide Phase 3: 28.7% Weight

Interesting thank you for sharing Very interesting to me

Available from: Mahmoud F, Mullen A, Sainsbury C, Rushworth GF, Yasin H, Abutheraa N et al (2023) Meta-analysis of factors associated with antidiabetic drug prescribing for type 2 diabetes mellitus

How far does the receptor-engagement scaling go

Medication and Program Details Participation demands continuous evaluation and involvement from both patients and healthcare providers: Prescriptions: Your physician must send prescriptions with the correct codes indicating eligibility

It engages the same two receptors as Mounjaro plus glucagon receptors

Pricing may depend on: Cost estimates will become clearer once approval and commercialization plans are finalized by Eli Lilly and regulatory bodies